In 2007, three new directors were elected to Merck’s Board: Thomas Glocer in
November, Steven Goldstone in September and Harry Jacobson in December. Dick
Clark, president and CEO of Merck, serves as chairman of the Board of
Directors. Merck’s Board of Directors has six standing committees: Audit,
Compensation and Benefits, Corporate Governance, Finance, Public Policy and
Social Responsibility, and Research. Board members and their committee
assignments are listed below.
Richard T. Clark
Chairman, President and Chief Executive Officer, Merck & Co., Inc. Age:
61.
Johnnetta B. Cole, Ph.D.
President Emerita of Spelman College and Bennett College for Women. Merck
Director since 1994. Age: 71. Committees: Corporate Governance, Finance,
Public Policy and Social Responsibility*
Thomas H. Glocer
Chief Executive Officer, Reuters Group PLC. Director, Reuters Group PLC.
Merck Director since 2007. Age: 48.
Steven F. Goldstone
Retired Chairman, Chief Executive Officer, RJR Nabisco, Inc.
Managing Partner, Silver Spring Group. Non-Executive Chairman, ConAgra
Foods, Inc. Director, Trane Inc. (formerly American Standard Companies, Inc.) and Greenhill &
Co., Inc. Merck Director since 2007. Age: 61.
William B. Harrison, Jr.
Retired Chairman of the Board, JP Morgan Chase & Co. Director, Cousins
Properties Incorporated. Merck Director since 1999. Age: 64. Committees:
Compensation and Benefits, Finance*, Public Policy and Social
Responsibility
Harry R. Jacobson, M.D.
Vice Chancellor, Health Affairs, Vanderbilt University Medical Center.
Director, CeleNova BioSciences, Inc., HealthGate Data Corporation, Ingram
Industries, Inc. and Kinetic Concepts, Inc. Merck Director since 2007.
Age: 60.
William N. Kelley, M.D.
Professor of Medicine, Biochemistry and Biophysics, University of
Pennsylvania School of Medicine. Director, Advanced Bio-Surfaces, Inc.,
Beckman Coulter, Inc., GenVec, Inc. and Polymedix, Inc. Merck Director
since 1992. Age: 68. Committees: Compensation and Benefits, Corporate
Governance, Research*
Rochelle B. Lazarus
Chairman and Chief Executive Officer, Ogilvy & Mather Worldwide.
Director, General Electric and New York Presbyterian Hospital. Merck
Director since 2004. Age: 60. Committees: Audit, Public Policy and Social
Responsibility
Thomas E. Shenk, Ph.D.
Elkins Professor, Princeton University. Director, Cell Genesys, Inc. and
CV Therapeutics, Inc. Merck Director since 2001. Age: 61. Committees:
Audit, Public Policy and Social Responsibility, Research
Anne M. Tatlock
Retired Chairman and Chief Executive Officer, Fiduciary Trust Company
International. Director, Fortune Brands, Inc. and Franklin Resources, Inc.
Merck Director since 2000. Age: 68. Committees: Compensation and
Benefits*, Corporate Governance, Finance
Samuel O. Thier, M.D.
Professor of Medicine and Health Care Policy, Emeritus, Harvard Medical
School. Director, Charles River Laboratories, Inc. Merck Director since
1994. Age: 70. Committees: Corporate Governance*, Public Policy
and Social Responsibility, Research
Wendell P. Weeks
Chairman and Chief Executive Officer, Corning Incorporated. Director,
Corning Incorporated. Merck Director since 2004. Age: 48. Committees:
Audit, Corporate Governance, Finance
Peter C. Wendell
Managing Director, Sierra Ventures. Chairman, Princeton University
Investment Co. Merck Director since 2003.
Age: 57. Committees:
Audit*, Compensation and Benefits, Research
* Indicates Committee Chairperson
